Delivery Order SPE2DB20D7059-SPE2DB26FGSH7
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,010.69 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) with an ultimate completion date of September 4, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S under a firm fixed-price contract valued at $4,928.37, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.20 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical distributor will perform this delivery order from its corporate office location...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $9,043.62 on October 29, 2025, for the supply of Lidocaine 5% Patch 30s. This competitive, firm fixed-price delivery order is not set-aside and is scheduled for completion by November 26, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. This award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,079.33 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of October 28, 2025. This competitive award, issued on October 27, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for...
- The Defense Logistics Agency (DLA) awarded a $1,366.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 14, 2025. This non-set-aside competitively awarded contract is classified as a child delivery order, indicating it derives from a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,742.45. This competitively awarded, non-set-aside contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025, and reflects a firm fixed price arrangement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,726.30 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of September 8, 2025. This non-competitive, firm fixed-price delivery order was issued on September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,297.25 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lidocaine 5% Patch 30s. This competitively awarded contract, utilizing firm fixed pricing with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,564.10 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGSH7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,092.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's broader contract relationship with DLA. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Lidocaine patch delivery fulfills DLA's ongoing medical supply chain requirements for pain management pharmaceuticals, supporting Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 11/12/25 |